Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / Pre-kliniske Evaluering av tyrosinkinasehemmere…
JoVE Journal
Medicine

A subscription to JoVE is required to view this content.

JoVE Journal Medicine
Pre-kliniske Evaluering av tyrosinkinasehemmere for behandling av akutt leukemi
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Journal (Medicine)
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Rat Heterotopic Abdominal Heart/Single-lung Transplantation in a Volume-loaded Configuration
Journal (Medicine)
Rat Heterotopic Abdominal Heart/Single-lung Transplantation in a Volume-loaded Configuration
 
Click here for the English version

Pre-kliniske Evaluering av tyrosinkinasehemmere for behandling av akutt leukemi

Article DOI: 10.3791/50720-v • 10:49 min • September 18th, 2013
September 18th, 2013 •
1,2, 1, 1, 1, 1
1Department of Pediatrics, University of Colorado Anschutz Medical Campus, 2Department of Bone Marrow Transplantation, University Hospital of Essen

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Receptor tyrosinkinaser er ectopically uttrykt i mange kreftformer og har blitt identifisert som terapeutiske mål i akutt leukemi. Denne manuskriptet beskriver en effektiv strategi for preklinisk evaluering av tyrosin kinase inhibitorer for behandling av akutt leukemi.

Tags

Medisin leukemi Receptor Protein-tyrosin kinaser Molecular målrettet terapi Therapeutics romanen lite molekyl hemmer reseptor tyrosin kinase leukemi
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter